SNWV.png
SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company
August 23, 2023 16:30 ET | SANUWAVE Health, Inc.
·       SANUWAVE Health Inc. (OTCQB: SNWV) has entered into a definitive merger agreement with SEP Acquisition Corp. (Nasdaq: SEPA). Upon closing, the combined company is expected to trade on...
SNWV.png
SANUWAVE Announces Q2 2023 Financial Results
August 11, 2023 06:00 ET | SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, Aug. 11, 2023 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today...
SNWV.png
SANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial Results
August 09, 2023 17:22 ET | SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, Aug. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live...
SNWV.png
SANUWAVE Signs Distribution Agreement With Pacific Medical, Inc.
August 01, 2023 07:30 ET | SANUWAVE Health, Inc.
Pacific Medical to bring its sales force of over 215 dedicated representatives covering seven western states to the SANUWAVE UltraMist line of directed energy wound care products. Long-term...
SNWV.png
SANUWAVE Health Appoints Industry Veteran Andrew Walko as President
July 31, 2023 07:30 ET | SANUWAVE Health, Inc.
Walko brings 17 years of Manufacturing, Production, Operations, and Logistics Experience, most recently as President of Biomerics, where he led a 170-person contract manufacturing organization EDEN...
SNWV.png
SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter Ended June 30, 2023
July 17, 2023 07:30 ET | SANUWAVE Health, Inc.
SANUWAVE is pleased to announce preliminary revenues of $4.5 million to $4.7 million for Q2 ended June 30, 2023 Results indicate 16-21% growth rate over Q2 2022, consistent with guidance provided...
SNWV.png
SANUWAVE Health, Inc. Appoints Morgan Frank as Chief Executive Officer
May 24, 2023 09:00 ET | SANUWAVE Health, Inc.
Frank Brings 29 Years of Experience in Life Sciences, Technology, and Capital Markets Kevin Richardson to Remain at SANUWAVE as Chief Strategic Officer and as a Member of the Board of Directors ...
SNWV.png
SANUWAVE Announces Q1 2023 Financial Results
May 12, 2023 07:30 ET | SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, May 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced 1st...
SNWV.png
SANUWAVE Will Host a Live Conference Call and Webcast May 12, 2023 at 9:00 AM to Provide a Financial and Business Update
May 11, 2023 07:30 ET | SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, May 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, will host a live conference call...
SNWV.png
SANUWAVE Health to Attend the 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) Conference
April 27, 2023 08:30 ET | SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, April 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to...